Literature DB >> 29669267

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.

Fabiana Almeida Curylofo-Zotti1, Muna S Elburki2, Priscilla Aparecida Oliveira3, Paulo Sérgio Cerri3, Leandro Alves Santos1, Hsi-Ming Lee2, Francis Johnson4, Lorne M Golub2, Carlos Rossa1, Morgana Rodrigues Guimarães-Stabili5.   

Abstract

OBJECTIVE: The purpose of this study was to compare the effects of the oral administration of natural curcumin and a chemically modified curcumin (CMC2.24) on osteoclast-mediated bone resorption, apoptosis, and inflammation in a murine model of experimental periodontal disease.
DESIGN: Fifty male rats were distributed among the following treatment groups: (i) 2% carboxymethylcellulose, (ii) CMC2.24 30 mg/kg body weight, (iii) Curcumin 100 mg/kg body weight and (iv) no treatment. Compounds were administered daily by oral intubation over a 15-day period of time. Periodontal disease was induced by injections of LPS (lipopolysaccharide) into the gingival tissues three times per week. Contralateral sides were injected with the same volume of PBS (phosphate buffered saline) vehicle. After 15 days, hemimaxillae and gingival tissues were harvested. Bone resorption was assessed by μCT (microcomputer tomography). Formalin-fixed, paraffin embedded histological sections were stained with haematoxylin/eosin (H/E) for the assessment of cellular infiltrate or subjected to immunohistochemistry for detecting TRAP (tartrate-resistant acid phosphatase)-positive cells and caspase-3. Apoptosis was assessed in the gingival tissues by DNA fragmentation.
RESULTS: CMC2.24 and curcumin caused a significant reduction of the inflammatory cell infiltrate, however μCT analysis showed that only CMC2.24 reduced bone resorption and the number of TRAP-positive multinucleated cells (osteoclasts). Curcumin, but not CMC2.24, significantly reduced the number of apoptotic cells in the gingival tissues and of osteocytes in the alveolar bone crest.
CONCLUSIONS: The results suggest that CMC2.24 and curcumin inhibit inflammation by different mechanisms, but only CMC2.24 was capable of reducing alveolar bone resorption in the LPS-induced model of periodontitis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone resorption; Chemically modified curcumin (CMC2.24); Inflammation; Lipopolysaccharide; Periodontal disease

Mesh:

Substances:

Year:  2018        PMID: 29669267     DOI: 10.1016/j.archoralbio.2018.04.007

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  15 in total

1.  Local application of curcumin-loaded nanoparticles as an adjunct to scaling and root planing in periodontitis: Randomized, placebo-controlled, double-blind split-mouth clinical trial.

Authors:  Cindy Grace Pérez-Pacheco; Natalie Ap Rodrigues Fernandes; Fernando Lucas Primo; Antonio Claudio Tedesco; Emily Bellile; Belen Retamal-Valdes; Magda Feres; Morgana Rodrigues Guimarães-Stabili; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-10-30       Impact factor: 3.573

2.  Photosensitizers attenuate LPS-induced inflammation: implications in dentistry and general health.

Authors:  Ana Carolina Fernandes Couto; Renan Villanova Homem de Carvalho; Guilherme Thomaz Pereira Brancini; Fernando Grine Martins; Carlos Arterio Sorgi; Raquel Assed Bezerra da Silva; Paulo Nelson-Filho; Francisco Wanderley Garcia Paula-Silva; Maria Cristina Borsatto; Gilberto Úbida Leite Braga; Arthur Belém Novaes Júnior
Journal:  Lasers Med Sci       Date:  2020-11-04       Impact factor: 3.161

Review 3.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

4.  Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells.

Authors:  Shilpi Goenka; Francis Johnson; Sanford R Simon
Journal:  Biomolecules       Date:  2021-04-30

Review 5.  The implication of the PD-1/PD-L1 checkpoint in chronic periodontitis suggests novel therapeutic opportunities with natural products.

Authors:  Christian Bailly
Journal:  Jpn Dent Sci Rev       Date:  2020-06-12

Review 6.  The Effect of Curcumin on the Differentiation of Mesenchymal Stem Cells into Mesodermal Lineage.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Saeideh Hajighasemi; Tannaz Jamialahmadi; Muhammed Majeed; Amirhossein Sahebkar
Journal:  Molecules       Date:  2019-11-07       Impact factor: 4.411

Review 7.  Periodontal therapeutics: Current host-modulation agents and future directions.

Authors:  Lorne M Golub; Hsi-Ming Lee
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 12.239

8.  Silencing matrix metalloproteinase-13 (Mmp-13) reduces inflammatory bone resorption associated with LPS-induced periodontal disease in vivo.

Authors:  Morgana R Guimaraes-Stabili; Marcell Costa de Medeiros; Danuza Rossi; Angelo Constantino Camilli; Cleslei Fernando Zanelli; Sandro Roberto Valentini; Luis Carlos Spolidorio; Keith Lough Kirkwood; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-11-02       Impact factor: 3.573

9.  Role for Lipids Secreted by Irradiated Peripheral Blood Mononuclear Cells in Inflammatory Resolution in Vitro.

Authors:  Layla Panahipour; Evgeniya Kochergina; Maria Laggner; Matthias Zimmermann; Michael Mildner; Hendrik J Ankersmit; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 6.208

Review 10.  Does Chemically Modified Curcumin Control the Progression of Periodontitis? A Systematic Review.

Authors:  Esam Dhaifullah; Hassan S Seayed; Diana Mostafa; Abdul Majeed M Alharbi; Waleed M Alotaibi
Journal:  J Exp Pharmacol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.